What's Going On With Fulcrum Therapeutics Stock On Thursday?
Fulcrum plummets 50% after scrapping lead sickle-cell drug on FDA concerns
FULC Stock Crashes After Hours: What Investors Need To Know
Fulcrum scraps sickle cell drug program after FDA raises cancer-risk concerns
What's Going On With Fulcrum Therapeutics Stock Tuesday?
Fulcrum Therapeutics Stock Rally Ignited By Promising Sickle Cell Results